Infinity Pharmaceuticals | 4:持股变动声明-董事 Perkins Adelene Q
Infinity Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Polar Capital Holdings Plc(2.3%),Polar Capital LLP(2.3%)
Infinity Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.95%)
Infinity Pharmaceuticals | 4:持股变动声明
Infinity Pharmaceuticals | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(2.6%)
Infinity Pharmaceuticals | 4:持股变动声明
Infinity Pharmaceuticals | 4:持股变动声明
Infinity Pharmaceuticals | 4:持股变动声明
Infinity Pharmaceuticals | 4:持股变动声明
Infinity Pharmaceuticals | 4:持股变动声明
Infinity Pharmaceuticals | 4:持股变动声明
Infinity Pharmaceuticals | 4:持股变动声明
Infinity Pharmaceuticals | 3:首次持股声明-董事 KANGO SUJAY
Infinity Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-BVF Partners L.P.(7.1%),BVF Inc.(7.1%)等
Infinity Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%)等
Infinity Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Polar Capital Holdings Plc(5.6%),Polar Capital LLP(5.6%)
Infinity Pharmaceuticals | SC 13G:超过5%持股股东披露文件-The Vanguard Group(6.50%)
Infinity Pharmaceuticals | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(7.5%)
Infinity Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Integrated Assets II LLC(0.8%),Millennium International Management LP(0.8%)等
Infinity Pharmaceuticals | 4:持股变动声明
暂无数据
暂无数据